Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease?

DOI: 10.5527/wjn.v7.i2.51

Keywords: Polycystic kidney disease, Copeptin, Biomarker

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text